glp-1 drugs adverse effects Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks A schematic overview of GLP-1

Telomeres, oxidative stress, and myocardial infarction

This effect may be further enhanced in a synergistic manner by probiotics through the reduction of NETs while exhibiting antioxidative properties that lower ROS production and cellular cytotoxicity (92)

51 The Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) trial reported that tirzepatide (10 mg or 15 mg) significantly reduced the apnoeahypopnea index in people with moderate to severe obstructive sleep apnoea and obesity

Anandhan, A

Interestingly, on undergoing a LOsG/ROS stress, -cells started to re-express fetal nuclear Neurog3 and to dramatically relocate pancreas/duodenum homeobox protein 1 (Pdx1) from the cytoplasm to the nucleus (Fig

It is not the whole story though